Skip to main content

Advertisement

Log in

Challenges and Opportunities of Epidemiological Studies to Reduce the Burden of Cancers in Young Adults

  • Cancer Epidemiology (MB Terry, Section Editor)
  • Published:
Current Epidemiology Reports Aims and scope Submit manuscript

Abstract

There are >1.9 million survivors of adolescent and young adult cancers (AYA, diagnosed at ages 15–39) living in the U.S. today. Epidemiologic studies to address the cancer burden in this group have been a relatively recent focus of the research community. In this article, we discuss approaches and data resources for cancer epidemiology and health services research in the AYA population. We consider research that uses data from cancer registries, vital records, healthcare utilization, and surveys, and the accompanying challenges and opportunities of each. To illustrate the strengths of each data source, we present example research questions or areas that are aligned with these data sources and salient to AYAs. Integrating the respective strengths of cancer registry, vital records, healthcare data, and survey-based studies sets the foundation for innovative and impactful research on AYA cancer treatment and survivorship to inform a comprehensive understanding of diverse AYA needs and experiences.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Data Availability

Not applicable.

Code Availability

Not applicable.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Lewis DR, et al. Adolescent and young adult cancer survival. J Natl Cancer Inst Monogr. 2014;2014(49):228–35.

    Article  PubMed  PubMed Central  Google Scholar 

  2. DeSantis CE, et al. Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin. 2014;64(4):252–71.

    Article  PubMed  Google Scholar 

  3. Keegan TH, et al. Comparison of cancer survival trends in the United States of adolescents and young adults with those in children and older adults. Cancer. 2016;122(7):1009–16.

    Article  PubMed  Google Scholar 

  4. The Adolescent and Young Adult Oncology Progress Review Group. Closing the gap: research and care imperatives for adolescents and young adults with cancer. August 2006, National Institutes of Health and National Cancer Institute. Available from: https://www.livestrong.org/sites/default/files/what-wedo/reports/ayao_prg_report_2006_final.pdf.

  5. Nass SJ, et al. Identifying and addressing the needs of adolescents and young adults with cancer: summary of an Institute of Medicine workshop. Oncologist. 2015;20(2):186–95.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Bleyer A, et al. Global assessment of cancer incidence and survival in adolescents and young adults. Pediatr Blood Cancer. 2017;64(9).

  7. Kinahan KE, et al. Promoting the shared-care model for adolescent and young adults with cancer: optimizing referrals and care coordination with primary care providers. J Natl Compr Canc Netw. 2017;15(1):38–44.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Overholser L, Kilbourn K, Liu A. Survivorship issues in adolescent and young adult oncology. Med Clin North Am. 2017;101(6):1075–84.

    Article  PubMed  Google Scholar 

  9. Parsons HM, et al. Young and uninsured: insurance patterns of recently diagnosed adolescent and young adult cancer survivors in the AYA HOPE study. Cancer. 2014;120(15):2352–60.

    Article  PubMed  Google Scholar 

  10. Albritton KH, et al. Site of oncologic specialty care for older adolescents in Utah. J Clin Oncol. 2007;25(29):4616–21.

    Article  PubMed  Google Scholar 

  11. Howell DL, et al. Access to pediatric cancer care by age, race, and diagnosis, and outcomes of cancer treatment in pediatric and adolescent patients in the State of Georgia. J Clin Oncol. 2007;25(29):4610–5.

    Article  PubMed  Google Scholar 

  12. Parsons HM, et al. Clinical trial participation and time to treatment among adolescents and young adults with cancer: does age at diagnosis or insurance make a difference? J Clin Oncol. 2011;29(30):4045–53.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Pollock BH, Krischer JP, Vietti TJ. Interval between symptom onset and diagnosis of pediatric solid tumors. J Pediatr. 1991;119(5):725–32.

    Article  CAS  PubMed  Google Scholar 

  14. Robbins AS, Lerro CC, Barr RD. Insurance status and distant-stage disease at diagnosis among adolescent and young adult patients with cancer aged 15 to 39 years: National Cancer Data Base, 2004 through 2010. Cancer. 2014;120(8):1212–9.

    Article  PubMed  Google Scholar 

  15. Keegan TH, et al. Medical care in adolescents and young adult cancer survivors: what are the biggest access-related barriers? J Cancer Surviv. 2014;8(2):282–92.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Faulk KE, et al. Assessment of enrollment characteristics for Children’s Oncology Group (COG) upfront therapeutic clinical trials 2004–2015. PLoS One. 2020;15(4):e0230824.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Children’s Oncology Group. Long-term follow up guidelines for survivors of childhood, adolescent, and young adult cancer, Version 4.0, 2013. Available from: http://www.survivorshipguidelines.org/pdf/LTFUGuidelines_40.pdf. Accessed 7 May 2021.

  18. Elena JW, et al. Leveraging epidemiology and clinical studies of cancer outcomes: recommendations and opportunities for translational research. J Natl Cancer Inst. 2013;105(2):85–94.

    Article  PubMed  Google Scholar 

  19. Logan S, et al. A systematic review of patient oncofertility support needs in reproductive cancer patients aged 14 to 45 years of age. Psychooncology. 2018;27(2):401–9.

    Article  CAS  PubMed  Google Scholar 

  20. NAACCR Certification Criteria. 2018 [cited 2021 12 May]; Available from: https://www.naaccr.org/certification-criteria/. Accessed 7 May 2021.

  21. Anderson C, Nichols HB. Trends in late mortality among adolescent and young adult cancer survivors. J Natl Cancer Inst. 2020;112(10):994–1002.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Anderson C, Smitherman AB, Nichols HB. Conditional relative survival among long-term survivors of adolescent and young adult cancers. Cancer. 2018;124(14):3037–43.

    Article  PubMed  Google Scholar 

  23. Tobin JL, et al. Estimating cancer treatment intensity from SEER cancer registry data: methods and implications for population-based registry studies of pediatric cancers. Cancer Causes Control. 2020;31(10):881–90.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Anderson C, et al. Validity of state cancer registry treatment information for adolescent and young adult women. Cancer Epidemiol, 2020;64. This article evaluates the validity of first treatment data within a state cancer registry.

  25. Bann CM, et al. Cancer survivors’ use of fertility preservation. J Womens Health (Larchmt). 2015;24(12):1030–7.

    Article  PubMed  Google Scholar 

  26. Forman EJ, Anders CK, Behera MA. A nationwide survey of oncologists regarding treatment-related infertility and fertility preservation in female cancer patients. Fertil Steril. 2010;94(5):1652–6.

    Article  PubMed  Google Scholar 

  27. Canada AL, Schover LR. The psychosocial impact of interrupted childbearing in long-term female cancer survivors. Psychooncology. 2012;21(2):134–43.

    Article  PubMed  Google Scholar 

  28. Hammond CT, et al. Non-Hodgkin’s lymphoma survivors’ fertility and sexual function-related information needs. Fertil Steril. 2008;90(4):1256–8.

    Article  PubMed  Google Scholar 

  29. Ethics Committee of the American Society for Reproductive, M., Fertility preservation and reproduction in cancer patients. Fertil Steril, 2005;83(6):1622–1628.

  30. Loren AW, et al. Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013;31(19):2500–10.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Network, N.C.C. NCCN clinical practice guidelines in oncology. adolescent and young adult (AYA) oncology. Version 2.2018. [cited 2017 11 October]; Available from: NCCN.org. Accessed 4 May 2021.

  32. Martinez F. Update on fertility preservation from the Barcelona International Society for Fertility Preservation-ESHRE-ASRM 2015 expert meeting: indications, results and future perspectives. Hum Reprod. 2017;32(9):1802–11.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Baxter NN, et al. A population-based study of rates of childbirth in recurrence-free female young adult survivors of non-gynecologic malignancies. BMC Cancer. 2013;13:30.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Dalberg K, Eriksson J, Holmberg L. Birth outcome in women with previously treated breast cancer–a population-based cohort study from Sweden. PLoS Med. 2006;3(9):e336.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Hartman M, et al. Birth rates among female cancer survivors: a population-based cohort study in Sweden. Cancer. 2013;119(10):1892–9.

    Article  PubMed  Google Scholar 

  36. Stensheim H, et al. Pregnancy after adolescent and adult cancer: a population-based matched cohort study. Int J Cancer. 2011;129(5):1225–36.

    Article  CAS  PubMed  Google Scholar 

  37. Anderson RA, et al. The impact of cancer on subsequent chance of pregnancy: a population-based analysis. Hum Reprod. 2018;33(7):1281–90.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Gerstl B, et al. Reproductive outcomes after a childhood and adolescent young adult cancer diagnosis in female cancer survivors: a systematic review and meta-analysis. J Adolesc Young Adult Oncol. 2018;7(6):627–42.

    Article  Google Scholar 

  39. van Dorp W, et al. Reproductive function and outcomes in female survivors of childhood, adolescent, and young adult cancer: a review. J Clin Oncol. 2018;36(21):2169–80.

    Article  PubMed  PubMed Central  Google Scholar 

  40. van der Kooi ALF, et al. Perinatal complications in female survivors of cancer: a systematic review and meta-analysis. Eur J Cancer. 2019;111:126–37.

    Article  PubMed  Google Scholar 

  41. Sabeti Rad Z, et al. Deliveries after malignant disease before pregnancy: maternal characteristics, pregnancy, and delivery complications. J Adolesc Young Adult Oncol. 2016;5(3):240–7.

    Article  PubMed  Google Scholar 

  42. Anderson C, et al. Birth outcomes among adolescent and young adult cancer survivors. JAMA Oncol. 2017;3(8):1078–84.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Hartnett KP, et al. Pregnancy after cancer: does timing of conception affect infant health? Cancer. 2018;124(22):4401–7.

    Article  PubMed  Google Scholar 

  44. van der Kooi ALF, et al. Counseling and surveillance of obstetrical risks for female childhood, adolescent, and young adult cancer survivors: recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Am J Obstet Gynecol. 2021;224(1):3–15.

    Article  PubMed  Google Scholar 

  45. Grover NS, et al. Young men with cancer experience low referral rates for fertility counseling and sperm banking. J Oncol Pract. 2016;12(5):465–71.

    Article  PubMed  Google Scholar 

  46. Armuand GM, et al. Sex differences in fertility-related information received by young adult cancer survivors. J Clin Oncol. 2012;30(17):2147–53.

    Article  PubMed  Google Scholar 

  47. Kim J, et al. Which patients pursue fertility preservation treatments? A multicenter analysis of the predictors of fertility preservation in women with breast cancer. Fertil Steril. 2012;97(3):671–6.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Lawson AK, et al. Disparities in counseling female cancer patients for fertility preservation. J Womens Health (Larchmt). 2017;26(8):886–91.

    Article  PubMed  Google Scholar 

  49. Chin HB, et al. Which female cancer patients fail to receive fertility counseling before treatment in the state of Georgia? Fertil Steril, 2016;106(7):1763–1771 e1.

  50. Edwards BK, et al. Annual Report to the Nation on the status of cancer, 1975–2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer. Cancer. 2014;120(9):1290–314.

    Article  PubMed  Google Scholar 

  51. Hwee S. U.S. Opioid prescribing trends for adolescent and young adult cancer patients in last year of life, 2002 – 2016: a study from the Clare Project. 2018. (Master’s thesis). Available from University of Washington Research Works: http://hdl.handle.net/1773/42376. Accessed 5 May 2021.

  52. Keegan THM, et al. Cardiovascular disease incidence in adolescent and young adult cancer survivors: a retrospective cohort study. J Cancer Surviv. 2018;12(3):388–97. This study demonstrates that cardiovascular disease risk can vary by sociodemographic factors.

    Article  PubMed  Google Scholar 

  53. Curtis MD, et al. Development and validation of a high-quality composite real-world mortality endpoint. Health Serv Res. 2018;53(6):4460–76.

    Article  PubMed  PubMed Central  Google Scholar 

  54. Chubak J, et al. The Cancer Research Network: a platform for epidemiologic and health services research on cancer prevention, care, and outcomes in large, stable populations. Cancer Causes Control. 2016;27(11):1315–23.

    Article  PubMed  PubMed Central  Google Scholar 

  55. Hahn EE, et al. Use of recommended posttreatment services for adolescent and young adult survivors of Hodgkin lymphoma. Cancer. 2019;125(9):1558–67.

    Article  PubMed  Google Scholar 

  56. Oeffinger KC, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med. 2006;355(15):1572–82.

    Article  CAS  PubMed  Google Scholar 

  57. Hudson MM, et al. Clinical ascertainment of health outcomes among adults treated for childhood cancer. JAMA. 2013;309(22):2371–81.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Reulen RC, et al. Long-term cause-specific mortality among survivors of childhood cancer. JAMA. 2010;304(2):172–9.

    Article  CAS  PubMed  Google Scholar 

  59. Hudson MM, et al. Age-dependent changes in health status in the Childhood Cancer Survivor cohort. J Clin Oncol. 2015;33(5):479–91.

    Article  PubMed  Google Scholar 

  60. Chao C, et al. Long-term health outcomes in survivors of childhood cancer diagnosed between 1990 and 2000 in a large US integrated health care system. J Pediatr Hematol Oncol. 2016;38(2):123–30.

    Article  PubMed  Google Scholar 

  61. Geenen MM, et al. Medical assessment of adverse health outcomes in long-term survivors of childhood cancer. Jama. 2007;297(24):2705–15.

    Article  CAS  PubMed  Google Scholar 

  62. Kenney LB, et al. Health status of the oldest adult survivors of cancer during childhood. Cancer. 2010;116(2):497–505.

    Article  PubMed  Google Scholar 

  63. Mertens AC, et al. Pulmonary complications in survivors of childhood and adolescent cancer. A report from the Childhood Cancer Survivor Study. Cancer, 2002;95(11):2431–2441.

  64. Madanat LM, et al. Hypothyroidism among pediatric cancer patients: a nationwide, registry-based study. Int J Cancer. 2008;122(8):1868–72.

    Article  CAS  PubMed  Google Scholar 

  65. de Vries S, et al. High burden of subsequent malignant neoplasms and cardiovascular disease in long-term Hodgkin lymphoma survivors. Br J Cancer. 2018;118(6):887–95.

    Article  PubMed  PubMed Central  Google Scholar 

  66. van Nimwegen FA, et al. Risk of heart failure in survivors of Hodgkin lymphoma: effects of cardiac exposure to radiation and anthracyclines. Blood. 2017;129(16):2257–65.

    Article  PubMed  PubMed Central  Google Scholar 

  67. van Nimwegen FA, et al. Radiation dose-response relationship for risk of coronary heart disease in survivors of Hodgkin lymphoma. J Clin Oncol. 2016;34(3):235–43.

    Article  PubMed  Google Scholar 

  68. van Nimwegen FA, et al. Cardiovascular disease after Hodgkin lymphoma treatment: 40-year disease risk. JAMA Intern Med. 2015;175(6):1007–17.

    Article  PubMed  Google Scholar 

  69. Feldman DR, et al. Predicting cardiovascular disease among testicular cancer survivors after modern cisplatin-based chemotherapy: application of the Framingham Risk Score. Clin Genitourin Cancer. 2018;16(4):e761–9.

    Article  PubMed  PubMed Central  Google Scholar 

  70. Fung C, et al. Toxicities associated with cisplatin-based chemotherapy and radiotherapy in long-term testicular cancer survivors. Adv Urol. 2018;2018:8671832.

    Article  PubMed  PubMed Central  Google Scholar 

  71. Fung C, et al. Multi-institutional assessment of adverse health outcomes among North American testicular cancer survivors after modern cisplatin-based chemotherapy. J Clin Oncol. 2017;35(11):1211–22.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  72. Kerns SL, et al. Cumulative burden of morbidity among testicular cancer survivors after standard cisplatin-based chemotherapy: a multi-institutional study. J Clin Oncol. 2018;36(15):1505–12.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  73. Harlan LC, et al. Recruitment and follow-up of adolescent and young adult cancer survivors: the AYA HOPE Study. J Cancer Surviv. 2011;5(3):305–14.

    Article  PubMed  PubMed Central  Google Scholar 

  74. Smith AW, et al. Understanding care and outcomes in adolescents and young adult with cancer: a review of the AYA HOPE study. Pediatr Blood Cancer, 2019;66(1):e27486. This article provides a summary of recent research from a seminal AYA survivor survey study.

  75. Chao C, et al. Exploring the feasibility of establishing a retrospective cohort of survivors of adolescent and young adult cancer to study long-term health outcomes in an integrated managed care environment. J Adolesc Young Adult Oncol. 2013;2(2):59–65.

    Article  PubMed  PubMed Central  Google Scholar 

  76. Lee JS, et al. Increased risk of second malignant neoplasms in adolescents and young adults with cancer. Cancer. 2016;122(1):116–23.

    Article  PubMed  Google Scholar 

  77. Keegan THM, et al. Second primary malignant neoplasms and survival in adolescent and young adult cancer survivors. JAMA Oncol. 2017;3(11):1554–7.

    Article  PubMed  PubMed Central  Google Scholar 

  78. Rugbjerg K, Olsen JH. Long-term risk of hospitalization for somatic diseases in survivors of adolescent or young adult cancer. JAMA Oncol. 2016;2(2):193–200.

    Article  PubMed  Google Scholar 

  79. Bright CJ, et al. Risk of cerebrovascular events in 178 962 five-year survivors of cancer diagnosed at 15 to 39 years of age: the TYACSS (Teenage and Young Adult Cancer Survivor Study). Circulation. 2017;135(13):1194–210.

    Article  PubMed  PubMed Central  Google Scholar 

  80. Kero AE, et al. Cardiovascular morbidity in long-term survivors of early-onset cancer: a population-based study. Int J Cancer. 2014;134(3):664–73.

    Article  CAS  PubMed  Google Scholar 

  81. van Laar M, et al. Cardiovascular sequelae in long-term survivors of young peoples’ cancer: a linked cohort study. Br J Cancer. 2014;110(5):1338–41.

    Article  PubMed  PubMed Central  Google Scholar 

  82. Smith L, et al. Respiratory morbidity in young people surviving cancer: population-based study of hospital admissions, treatment-related risk factors and subsequent mortality. Int J Cancer. 2019;145(1):20–8.

    Article  CAS  PubMed  Google Scholar 

  83. Derouen MC, et al. A population-based observational study of first-course treatment and survival for adolescent and young adult females with breast cancer. J Adolesc Young Adult Oncol. 2013;2(3):95–103.

    Article  PubMed  PubMed Central  Google Scholar 

  84. Keegan TH, et al. Sociodemographic disparities in differentiated thyroid cancer survival among adolescents and young adults in california. Thyroid. 2015;25(6):635–48.

    Article  PubMed  PubMed Central  Google Scholar 

  85. Keegan TH, et al. Impact of breast cancer subtypes on 3-year survival among adolescent and young adult women. Breast Cancer Res. 2013;15(5):R95.

    Article  PubMed  PubMed Central  Google Scholar 

  86. Aizer AA, et al. Cancer-specific outcomes among young adults without health insurance. J Clin Oncol. 2014;32(19):2025–30.

    Article  PubMed  PubMed Central  Google Scholar 

  87. Kent EE, et al. Socioeconomic impacts on survival differ by race/ethnicity among adolescents and young adults with non-Hodgkin’s lymphoma. J Cancer Epidemiol. 2010;2010:824691.

    Article  PubMed  PubMed Central  Google Scholar 

  88. Rosenberg AR, et al. Insurance status and risk of cancer mortality among adolescents and young adults. Cancer. 2015;121(8):1279–86.

    Article  PubMed  Google Scholar 

  89. Keegan TH, et al. Impact of treatment and insurance on socioeconomic disparities in survival after adolescent and young adult Hodgkin lymphoma: a population-based study. Cancer Epidemiol Biomarkers Prev. 2016;25(2):264–73.

    Article  PubMed  PubMed Central  Google Scholar 

  90. Keegan T, et al. Difference in cardiovascular disease incidence by sociodemographic factors in adolescent and young adult (AYA) cancer survivors. J Clin Oncol. 2017;35(15_suppl):6565–6565.

  91. Keegan THM, et al. Sociodemographic disparities in the occurrence of medical conditions among adolescent and young adult Hodgkin lymphoma survivors. Cancer Causes Control. 2018;29(6):551–61.

    Article  PubMed  PubMed Central  Google Scholar 

  92. Abrahao R, et al. Chronic medical conditions and late effects following non-Hodgkin lymphoma in HIV-uninfected and HIV-infected adolescents and young adults: a population-based study. Br J Haematol. 2020;190(3):371–84.

    Article  PubMed  PubMed Central  Google Scholar 

  93. Gingrich AA, et al. Disparities in the occurrence of late effects following treatment among adolescent and young adult melanoma survivors. Cancer Epidemiol Biomarkers Prev. 2020;29(11):2195–202.

    Article  PubMed  PubMed Central  Google Scholar 

  94. Muffly L, et al. Late effects in survivors of adolescent and young adult acute lymphoblastic leukemia. JNCI Cancer Spectr, 2020;4(4):pkaa025.

  95. Semrad TJ, et al. Influence of socioeconomic status on incident medical conditions in two-year survivors of adolescent or young adult differentiated thyroid cancer. J Adolesc Young Adult Oncol. 2021;10(5):521–33.

    Article  PubMed  PubMed Central  Google Scholar 

  96. Chao C, et al. Chronic comorbidities among survivors of adolescent and young adult cancer. J Clin Oncol. 2020;38(27):3161–74. This article shows the risk of developing chronic comorbidities is higher in AYA survivors versus the general population.

    Article  PubMed  PubMed Central  Google Scholar 

  97. Chao C, et al. Cardiovascular disease risk profiles in survivors of adolescent and young adult (AYA) cancer: the Kaiser Permanente AYA Cancer Survivors Study. J Clin Oncol. 2016;34(14):1626–33.

    Article  CAS  PubMed  Google Scholar 

  98. Keegan TH, et al. Medical care in adolescents and young adult cancer survivors: what are the biggest access-related barriers? J Cancer Surviv. 2014;8(2):282–92.

    Article  PubMed  PubMed Central  Google Scholar 

  99. Blanch-Hartigan D, et al. Trends in cancer survivors’ experience of patient-centered communication: results from the Health Information National Trends Survey (HINTS). J Cancer Surviv. 2016;10(6):1067–77.

    Article  PubMed  Google Scholar 

  100. Chawla N, et al. Quality of patient-provider communication among cancer survivors: findings from a nationally representative sample. J Oncol Pract. 2016;12(12):e964–73.

    Article  PubMed  PubMed Central  Google Scholar 

  101. Chawla N, et al. Patient-provider communication during post-treatment breast cancer care: gindings from a pilot project. J Clin Oncol. 2017;35(5):91–91.

    Article  Google Scholar 

  102. Chawla N, et al. Unveiling SEER-CAHPS(R): a new data resource for quality of care research. J Gen Intern Med. 2015;30(5):641–50.

    Article  PubMed  PubMed Central  Google Scholar 

  103. de Moor JS, et al. Access to cancer care and general medical care services among cancer survivors in the United States: an analysis of 2011 medical expenditure panel survey data. Public Health Rep. 2016;131(6):783–90.

    Article  PubMed  PubMed Central  Google Scholar 

  104. Dowling EC, et al. Lost productivity and burden of illness in cancer survivors with and without other chronic conditions. Cancer. 2013;119(18):3393–401.

    Article  PubMed  Google Scholar 

  105. Finney Rutten LJ, et al. Cancer-related information seeking among cancer survivors: trends over a decade (2003–2013). J Cancer Educ. 2016;31(2):348–57.

    Article  PubMed  Google Scholar 

  106. Guy GP Jr, et al. Healthcare expenditure burden among non-elderly cancer survivors, 2008–2012. Am J Prev Med. 2015;49(6 Suppl 5):S489-97.

    Article  PubMed  PubMed Central  Google Scholar 

  107. Hays RD, et al. Measurement equivalence of the Consumer Assessment of Healthcare Providers and Systems (CAHPS((R))) Medicare survey items between Whites and Asians. Qual Life Res. 2017;26(2):311–8.

    Article  PubMed  Google Scholar 

  108. Yabroff KR, et al. Financial hardship associated with cancer in the United States: findings from a population-based sample of adult cancer survivors. J Clin Oncol. 2016;34(3):259–67.

    Article  PubMed  Google Scholar 

  109. Husson O, et al. Health-related quality of life in adolescent and young adult patients with cancer: a longitudinal study. J Clin Oncol. 2017;35(6):652–9. This article provides information on health-related quality of life measures in the AYA cancer patient population over 24 months post-diagnosis.

    Article  PubMed  Google Scholar 

  110. Dillman DA, Smyth JD, Christian LM. Internet, phone, mail, and mixed-mode surveys: the tailored design method, 4th edition. 2014, John Wiley & Sons, Inc., Hoboken, NJ 528

  111. DeRouen MC, et al. Cancer-related information needs and cancer’s impact on control over life influence health-related quality of life among adolescents and young adults with cancer. Psychooncology. 2015;24(9):1104–15.

    Article  PubMed  PubMed Central  Google Scholar 

  112. Smith AW, et al. Health-related quality of life of adolescent and young adult patients with cancer in the United States: the Adolescent and Young Adult Health Outcomes and Patient Experience study. J Clin Oncol. 2013;31(17):2136–45.

    Article  PubMed  PubMed Central  Google Scholar 

  113. Smith AW, et al. Unmet support service needs and health-related quality of life among adolescents and young adults with cancer: the AYA HOPE study. Front Oncol. 2013;3:75.

    Article  PubMed  PubMed Central  Google Scholar 

  114. Keegan TH, et al. Unmet adolescent and young adult cancer survivors information and service needs: a population-based cancer registry study. J Cancer Surviv. 2012;6(3):239–50.

    Article  PubMed  PubMed Central  Google Scholar 

  115. Kent EE, et al. Talking about cancer and meeting peer survivors: social information needs of adolescents and young adults diagnosed with cancer. J Adolesc Young Adult Oncol. 2013;2(2):44–52.

    Article  PubMed  PubMed Central  Google Scholar 

  116. Wu XC, et al. Impact of the AYA HOPE comorbidity index on assessing health care service needs and health status among adolescents and young adults with cancer. Cancer Epidemiol Biomarkers Prev. 2015;24(12):1844–9.

    Article  PubMed  PubMed Central  Google Scholar 

  117. Howards PP, et al. Comparison of young adult female cancer survivors recruited from a population-based cancer registry to eligible survivors. Cancer Epidemiol Biomarkers Prev. 2021;30(4):727–35. This article provides information on AYA participation in survey research based on cancer registry identification.

    Article  PubMed  PubMed Central  Google Scholar 

  118. Nichols HB, et al. The adolescent and young adult (AYA) horizon study: an AYA cancer survivorship cohort. Cancer Epidemiol Biomarkers Prev. 2021;30(5):857–66. This article provides information on AYA participation in survey research based on cancer registry or health system identification.

    Article  PubMed  PubMed Central  Google Scholar 

  119. Little RJA, Rubin DB. Statistical analysis with missing data. 2nd ed. 2002, Wiley, New York, NY

  120. Vicari S. Twitter and non-elites: interpreting power dynamics in the life story of the (#)BRCA Twitter stream. Soc Media Soc. 2017;3(3):2056305117733224.

    PubMed  PubMed Central  Google Scholar 

  121. Gordon S. Online communities as agents of change and social movements. Advances in social networking and online communities book series. 2017, IGI Global, Information Science Reference, an imprint of IGI Global, Hershey, PA.

  122. Smith A, Anderson M. Social media use in 2018: a majority of Americans use Facebook and YouTube, but young adults are especially heavy users of Snapchat and Instagram. 2018 [cited 2021; Available from: https://www.pewresearch.org/internet/2018/03/01/social-media-use-in-2018/. Accessed 5 May 2021.

  123. Attai DJ, et al. Twitter social media is an effective tool for breast cancer patient education and support: patient-reported outcomes by survey. J Med Internet Res. 2015;17(7):e188.

    Article  PubMed  PubMed Central  Google Scholar 

  124. Perales MA, et al. Social media and the adolescent and young adult (AYA) patient with cancer. Curr Hematol Malig Rep. 2016;11(6):449–55.

    Article  PubMed  PubMed Central  Google Scholar 

  125. Wojcik S, Hughes A. Sizing up Twitter users: U.S. adult Twitter users are younger and more likely to be Democrats than the general public. Most users rarely tweet, but the most prolific 10% create 80% of tweets from adult U.S. users. 2019 [cited 2021; Available from: https://www.pewresearch.org/internet/2019/04/24/sizing-up-twitter-users/. Accessed 5 May 2021.

  126. Tariq S, Woodman J. Using mixed methods in health research. JRSM Short Rep. 2013;4(6):2042533313479197.

    Article  PubMed  PubMed Central  Google Scholar 

  127. S.292 – 115th Congress (2017-2018): Childhood Cancer Survivorship, Treatment, Access, and Research Act of 2018 or the Childhood Cancer STAR Act. 2018 June 5. https://www.congress.gov/bill/115th-congress/senate-bill/292.

  128. Research to reduce morbidity and improve care for pediatric, and adolescent and young adult (AYA) cancer survivors (R01 Clinical Trial Optional). 2021 [cited 2021 25 June]; Available from: https://grants.nih.gov/grants/guide/rfa-files/rfa-ca-20-027.html. Accessed 5 May 2021.

  129. Adams SC, et al. Young adult cancer survivorship: recommendations for patient follow-up, exercise therapy, and research. JNCI Cancer Spectr, 2021;5(1):pkaa099.

Download references

Funding

This research was supported by a grant from the National Cancer Institute (P01CA233432, awarded to Drs. Chubak, Hahn, Keegan, Kushi, and Nichols).

Author information

Authors and Affiliations

Authors

Contributions

All authors contributed to the drafting and final review of this manuscript

Corresponding author

Correspondence to Hazel B. Nichols.

Ethics declarations

Ethics Approval

Not applicable.

Consent to Participate

Not applicable.

Consent for Publication

Not applicable.

Conflict of Interest

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Jessica Chubak, Erin E. Hahn, Theresa H.M. Keegan, and Lawrence H. Kushi contributed as co-senior authors.

This article is part of the Topical Collection on Cancer Epidemiology

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nichols, H.B., Wernli, K.J., Chawla, N. et al. Challenges and Opportunities of Epidemiological Studies to Reduce the Burden of Cancers in Young Adults. Curr Epidemiol Rep 10, 115–124 (2023). https://doi.org/10.1007/s40471-022-00286-9

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40471-022-00286-9

Keywords

Navigation